European Archives - Page 34 of 1164 - European Medical Journal

Tezepelumab Achieves Clinical Remission in Severe Asthma

Interestingly, the study also revealed a disconnect between clinical and biological remission.

Addressing the Burden of Atopic Dermatitis on the Head and Neck

Explore the impact of atopic dermatitis on visible areas like the head and neck, affecting approximately 70% of patients with moderate to…

EMJ Allergy & Immunology 10 [Supplement 2] 2025

Hereditary angioedema (HAE) attacks can be debilitating and potentially life-threatening, particularly when they affect the abdomen or…

Berotralstat for HAE Prophylaxis

Hereditary angioedema (HAE) attacks can be debilitating and potentially life-threatening, particularly when they affect the…

King’s Fund sheds light on access to medicine in UK

The King’s Fund in the UK has released an updated explainer on the availability of new medicines in the UK’s NHS.

Pemafibrate Reduces Liver Fat and Heart Disease Risk

A study has revealed that pemafibrate is more effective than omega-3 fatty acid ethyl in reducing fatty liver index.

Beta-Blocker Discontinuation After Myocardial Infarction Linked to Increased Risks

Beta-blocker interruption after heart attack raises blood pressure and heart rate, increasing risks especially in hypertensive patients.

Study Links Autoantibodies to Lung Fibrosis Risk

Patients with anti-synthetase syndrome-associated interstitial lung disease show distinct lung imaging and clinical profiles depending on their antibody type, according to a new study.

Machine Learning Tool Stratifies Postpartum Depression Risk

A large-scale study has developed a predictive model using routine clinical data to identify patients at high risk of postpartum depression before they leave the hospital.

Breaking Barriers in Lung Cancer: Driving Change Through Early Screening

Discover insights into pioneering early detection efforts, the challenge of public misconceptions, and innovations reshaping lung cancer screening and diagnosis.